Primary Site >> Colorectal Cancer
Gene >> CXCL5
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
Ref: Expression and gene polymorphisms of the chemokine CXCL5 in colorectal cancer patients. PMID: 17549409 |
Ref: Disrupted expression of CXCL5 in colorectal cancer is associated with rapid tumor formation in rats and poor prognosis in patients. PMID: 18413816 Ref: ELR+ CXC chemokine expression in benign and malignant colorectal conditions. PMID: 18578857 |
Ref: Five quantitative trait loci control radiation-induced adenoma multiplicity in Mom1R Apc Min/+ mice. PMID: 19194513 |
Ref: Tumour tissue microenvironment can inhibit dendritic cell maturation in colorectal cancer. PMID: 22125641 |
Ref: Neutrophil transintestinal epithelial migration to CXCR2 ligands is regulated by adenosine. PMID: 21857250 Ref: CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer. PMID: 22197219 |
Ref: IL-15 suppresses colitis-associated colon carcinogenesis by inducing antitumor immunity. PMID: 26405589 Ref: Network regularised Cox regression and multiplex network models to predict disease comorbidities and survival of cancer. PMID: 26611766 |
Ref: Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling. PMID: 26364612 |
Ref: Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3beta/beta-catenin pathways. PMID: 28356111 Ref: Overexpression of CXCR2 predicts poor prognosis in patients with colorectal cancer. PMID: 28415702 Ref: Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy. PMID: 28691930 |
Ref: Development of a bifunctional nanobiosensor for screening and detection of chemokine ligand in colorectal cancer cell line. PMID: 28954256 Ref: Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis. PMID: 29743818 Ref: Silencing NIK potentiates anti-VEGF therapy in a novel 3D model of colorectal cancer angiogenesis. PMID: 29983872 Ref: Loss of solute carrier family 7 member 2 exacerbates inflammation-associated colon tumorigenesis. PMID: 30202097 Ref: Clinical Value of CXCL5 for Determining of Colorectal Cancer PMID: 30255816 |